Skip to main content

Peer Review reports

From: Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database

Original Submission
18 Aug 2023 Submitted Original manuscript
2 Sep 2023 Reviewed Reviewer Report - Siquan Wang
25 Sep 2023 Reviewed Reviewer Report
26 Sep 2023 Reviewed Reviewer Report
23 Oct 2023 Author responded Author comments - Jianxing Zhou
Resubmission - Version 2
23 Oct 2023 Submitted Manuscript version 2
29 Oct 2023 Reviewed Reviewer Report
14 Nov 2023 Reviewed Reviewer Report - Siquan Wang
4 Dec 2023 Author responded Author comments - Jianxing Zhou
Resubmission - Version 3
4 Dec 2023 Submitted Manuscript version 3
16 Dec 2023 Reviewed Reviewer Report
22 Dec 2023 Reviewed Reviewer Report
2 Jan 2024 Author responded Author comments - Jianxing Zhou
Resubmission - Version 4
2 Jan 2024 Submitted Manuscript version 4
11 Jan 2024 Reviewed Reviewer Report
17 Jan 2024 Author responded Author comments - Jianxing Zhou
Resubmission - Version 5
17 Jan 2024 Submitted Manuscript version 5
18 Jan 2024 Author responded Author comments - Jianxing Zhou
Resubmission - Version 6
18 Jan 2024 Submitted Manuscript version 6
22 Jan 2024 Author responded Author comments - Jianxing Zhou
Resubmission - Version 7
22 Jan 2024 Submitted Manuscript version 7
24 Jan 2024 Author responded Author comments - Jianxing Zhou
Resubmission - Version 8
24 Jan 2024 Submitted Manuscript version 8
Publishing
25 Jan 2024 Editorially accepted
14 Feb 2024 Article published 10.1186/s12916-024-03274-6

You can find further information about peer review here.

Back to article page